AIM
ARKG icon

ARK Investment Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

ARK Investment Management’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,200
Closed -$72K – 232
2022
Q3 		$72K Hold
2,200
– – ﹤0.01% 239
2022
Q2 		$71K Hold
2,200
– – ﹤0.01% 341
2022
Q1 		$101K Buy
+2,200
New +$105K ﹤0.01% 343

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

ARK Investment Management's ARKG Position: Q1 2026 in Review

ARK Investment Management increased its ARK Genomic Revolution ETF (ARKG) stake by 35% in Q1 2026, buying an estimated $51.1K and bringing the position to 6,773 shares worth $179K. The position accounts for ﹤0.01% of the portfolio, ranked #169.

ARK Investment Management first reported a position in ARKG in Q4 2020 and has held it in 22 quarters since. The position peaked at $3.27M in Q4 2021. 218 funds tracked by Wall St. Rank hold ARKG as of Q1 2026.

  • ARK Investment Management held 6,773 shares of ARK Genomic Revolution ETF worth $179K as of Q1 2026.
  • ARK Investment Management bought 1,744 ARK Genomic Revolution ETF shares in Q1 2026, an estimated $51.1K.
  • ARK Genomic Revolution ETF made up ﹤0.01% of ARK Investment Management's portfolio in Q1 2026, its #169 holding.
  • ARK Investment Management first reported a position in ARK Genomic Revolution ETF in Q4 2020 and has held it in 22 quarters since.
  • ARK Investment Management's ARK Genomic Revolution ETF position peaked at $3.27M in Q4 2021.
  • 218 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2026.

Based on ARK Investment Management's 13F filing for Q1 2026, filed 12 May 2026.